LDL induces Saos2 osteoblasts death via Akt pathways responsive to a neutral sphingomyelinase inhibitor
- 26 January 2006
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 98 (3), 661-671
- https://doi.org/10.1002/jcb.20807
Abstract
Atherosclerosis is epidemiologically associated with postmenopausal osteoporosis (OP) presumably by common etiologic factors, reflecting a state of co-morbidity in aging. Osteoblasts make a significant facet of this co-morbidity state. Since oxidized low-density lipoprotein (oxLDL) is a major factor in generation of vascular wall pathology, we examined the ability of native LDL (nLDL) and oxLDL to induce Saos2 osteoblasts growth arrest. OxLDL induced Saos2 cell death with morphological features of apoptosis that was inhibited mainly by caspase-9 and partially by caspase-3 but not by caspase-8 inhibitors. nLDL, like oxLDL, has induced cell death, where 60% (P = 0.00033) and 30% (P = 0.075, ns) of the cell death, respectively, could be inhibited by scyphostatin (a neutral sphingomyelinase [nSMase] inhibitor). Upon similar condition, nLDL inhibited the phosphorylation of Akt and two of its downstream targets, fork head receptor (FKHR) and glycogen synthase kinase-3 (GSK3). This is a pathway that stimulates cell survival and proliferation. nLDL has also induced an increase in the proapoptotic Bcl-Xs and it has diminished the potential antiapoptotic Src kinase activity. At the 4 h time-point, upon a substantial decrease in nLDL-induced Akt phosphorylation, scyphostatin has inhibited the reduction in FKHR and GSK3 phosphorylation but inexplicably not that of Akt. Scyphostatin has also corrected the reduction in Src kinase activity. Taken together, the results indicate that nLDL has induced apoptosis in Saos2 osteoblasts by inactivation of the pathway downstream to Akt using nSMase, and by involvement of Src kinase. Inferring that caspase-9 was the main executioner (rather than caspase-8 and-3) in Saos2 cell death, indicates that the nSMase-induced release of ceramide, directly activated the intrinsic mitochondrial apoptotic pathway. With regard to the Akt inactivation by nLDL, Saos2 osteoblasts responded in an opposite fashion to the response reported by others, in macrophages. J. Cell. Biochem. 98: 661–671, 2006.Keywords
This publication has 40 references indexed in Scilit:
- CSK negatively regulates nerve growth factor induced neural differentiation and augments AKT kinase activityExperimental Cell Research, 2005
- Role of Caspases in Ox-LDL–Induced Apoptotic Cascade in Human Coronary Artery Endothelial CellsCirculation Research, 2004
- Apolipoprotein AI as Therapy for Atherosclerosis: Does the Future of Preventive Cardiology Include Weekly Injections of the HDL Protein?Molecular Interventions, 2003
- Oxidized LDL-Induced Smooth Muscle Cell Proliferation Involves the EGF Receptor/PI-3 Kinase/Akt and the Sphingolipid Signaling PathwaysArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Cardiovascular disease and osteoporosis: is there a link between lipids and bone?Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2002
- Statins and Bone Formation.Current Pharmaceutical Design, 2001
- Transcriptional Regulation of the BCL-X Gene by NF-κB Is an Element of Hypoxic Responses in the Rat BrainNeurochemical Research, 2001
- Targeting HDL-mediated cellular cholesterol efflux for the treatment and prevention of atherosclerosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1999
- Osteoporosis and Coronary Atherosclerosis in Asymptomatic Postmenopausal WomenCalcified Tissue International, 1998
- Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.JCI Insight, 1992